SEC Company Response from Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704) (CLRB) — Nov 17, 2017
Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704)
Date: Nov. 17, 2017 · CIK: 0001279704 · Accession: 0001144204-17-059942
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-218514, 333-221468
Letter
CELLECTAR BIOSCIENCES, INC.
3301 Agriculture Drive
Madison, WI 53716
November 17, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ada D. Sarmento
Re: Cellectar Biosciences, Inc.
Registration Statement on Form S-1
Filed November 9, 2017
File No. 333-221468
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-218514), as amended, be accelerated so that the Registration Statement will become effective at 4:00 p.m. on November 22, 2017, or as soon as practicable thereafter.
The cooperation of the staff in meeting our request is very much appreciated. If you have any questions or comments, please contact Gregory J. Lynch of Michael Best & Friedrich LLP at (608) 283-2240 or gjlynch@michaelbest.com. Thank you for your assistance with these matters.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
CELLECTAR BIOSCIENCES, INC.
3301 Agriculture Drive
Madison, WI 53716
November 17, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ada D. Sarmento
Re:
Cellectar Biosciences, Inc.
Registration Statement on Form S-1
Filed November 9, 2017
File No. 333-221468
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities
Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that
the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-218514), as amended, be accelerated
so that the Registration Statement will become effective at 4:00 p.m. on November 22, 2017, or as soon as practicable thereafter.
The
cooperation of the staff in meeting our request is very much appreciated. If you have any questions or comments, please contact
Gregory J. Lynch of Michael Best & Friedrich LLP at (608) 283-2240 or
gjlynch@michaelbest.com. Thank you for your assistance with these matters.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
By:
/s/ James V. Caruso
James V. Caruso, President and Chief Executive Officer
cc:
John P. Hamill
Gregory J. Lynch